| Mr Maher Saegh, MD | |
|
1111 6th Ave, Des Moines, IA 50314-2613 | |
| (515) 247-4240 | |
| (515) 247-4239 |
| Full Name | Mr Maher Saegh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 1111 6th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457322216 | NPI | - | NPPES |
| 36915 | Other | IA | WELLMARK BCBS |
| 0440420 | Medicaid | IA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clarke County Public Hospital | 1951219328 | 27 |
| Cogent Healthcare Of Iowa, Pc | 3779517941 | 52 |
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Knoxville Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770591661 PECOS PAC ID: 6608787056 Enrollment ID: O20031119000804 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Hancock County Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689721318 PECOS PAC ID: 9739080425 Enrollment ID: O20040115001023 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Clarke County Public Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023045804 PECOS PAC ID: 1951219328 Enrollment ID: O20040224000636 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Cogent Healthcare Of Iowa, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982654497 PECOS PAC ID: 3779517941 Enrollment ID: O20050927000304 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Clarke County Public Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1114954997 PECOS PAC ID: 1951219328 Enrollment ID: O20061104000094 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Entity Name | Sound Physicians Of Iowa Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912398249 PECOS PAC ID: 9638497928 Enrollment ID: O20150416002374 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Maher Saegh, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 247-4240 | Mr Maher Saegh, MD 1111 6th Ave, Des Moines, IA 50314-2613 Ph: (515) 247-4240 |
News Archive
Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.
Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today financial results for the three months and full year ended December 31, 2013.
Research published in the New England Journal of Medicine suggests that pre-hospital advanced life support training does not increase the survival rate for people who experience a cardiac arrest outside of a hospital. On the other hand, bystander CardioPulmonary Resuscitation and rapid defibrillation programs are crucial interventions that can significantly impact survival rates.
Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.
Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
› Verified 9 days ago
Dr. Yi Jie Hammonds, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1415 Woodland Ave Ste 140, Des Moines, IA 50309 Phone: 515-241-5995 | |
Aubrey Anderson Reese, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-4497 | |
Dr. Patrick Harlan Tracy, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-4240 Fax: 515-247-4239 | |
Joseph Thomas Johnson, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 400, Des Moines, IA 50309 Phone: 515-241-4019 Fax: 515-241-4051 | |
Carol L Horner, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-4240 Fax: 515-247-4239 | |
Dr. Marina V. Stankovich, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Avenue, Des Moines, IA 50314 Phone: 515-247-4240 Fax: 515-247-4239 | |
Sophia Kang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave # W3, Des Moines, IA 50314 Phone: 515-643-8350 Fax: 515-643-5824 |